| Cytochrome c oxidase | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 | |||||||||
| Identifiers | |||||||||
| EC no. | 1.9.3.1 | ||||||||
| CAS no. | 9001-16-5 | ||||||||
| Databases | |||||||||
| IntEnz | IntEnz view | ||||||||
| BRENDA | BRENDA entry | ||||||||
| ExPASy | NiceZyme view | ||||||||
| KEGG | KEGG entry | ||||||||
| MetaCyc | metabolic pathway | ||||||||
| PRIAM | profile | ||||||||
| PDB structures | RCSB PDBPDBePDBsum | ||||||||
| Gene Ontology | AmiGO /QuickGO | ||||||||
| |||||||||
| Cytochrome c oxidase | |
|---|---|
 | |
| Identifiers | |
| Symbol | Cytochrome c oxidase |
| OPM superfamily | 4 |
| OPM protein | 2dyr |
| Membranome | 257 |
Theenzymecytochrome c oxidase orComplex IV (wasEC1.9.3.1, now reclassified as a translocaseEC7.1.1.9) is a largetransmembrane protein complex found inbacteria,archaea, and themitochondria ofeukaryotes.[1]
It is the last enzyme in therespiratoryelectron transport chain ofcells located in themembrane. It receives an electron from each of fourcytochrome c proteins and transfers them to oneoxygen molecule and fourprotons, producing two molecules of water. In addition to binding the four protons from the inner aqueous phase, it transports another four protons across the membrane, increasing the transmembrane difference of protonelectrochemical potential, which theATP synthase then uses to synthesizeATP.
The complex is a largeintegral membrane protein composed of severalmetal prosthetic sites and 13[2] protein subunits in mammals. In mammals, ten subunits are nuclear in origin, and three are synthesized in the mitochondria. The complex contains twohemes, acytochrome a andcytochrome a3, and two copper centers, the CuA and CuB centers.[3] In fact, the cytochrome a3 and CuB form a binuclear center that is the site of oxygen reduction.Cytochrome c, which is reduced by the preceding component of the respiratory chain (cytochrome bc1 complex, Complex III), docks near the CuA binuclear center and passes an electron to it, being oxidized back to cytochrome c containing Fe3+. The reduced CuA binuclear center now passes an electron on to cytochrome a, which in turn passes an electron on to the cytochrome a3>-CuB binuclear center. The two metal ions in this binuclear center are 4.5 Å apart and coordinate ahydroxide ion in the fully oxidized state.
Crystallographic studies of cytochrome c oxidase show an unusual post-translational modification, linking C6 of Tyr(244) and the ε-N of His(240) (bovine enzyme numbering). It plays a vital role in enabling the cytochrome a3- CuB binuclear center to accept four electrons in reducing molecular oxygen and four protons to water. The mechanism of reduction was formerly thought to involve aperoxide intermediate, which was believed to lead tosuperoxide production. However, the currently accepted mechanism involves a rapid four-electron reduction involving immediate oxygen–oxygen bond cleavage, avoiding any intermediate likely to form superoxide.[4]: 865–866
| No. | Subunit name | Human protein | Protein description fromUniProt | Pfam family with Human protein |
|---|---|---|---|---|
| 1 | Cox1 | COX1_HUMAN | Cytochrome c oxidase subunit 1 | PfamPF00115 |
| 2 | Cox2 | COX2_HUMAN | Cytochrome c oxidase subunit 2 | PfamPF02790,PfamPF00116 |
| 3 | Cox3 | COX3_HUMAN | Cytochrome c oxidase subunit 3 | PfamPF00510 |
| 4 | Cox4i1 | COX41_HUMAN | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | PfamPF02936 |
| 5 | Cox4a2 | COX42_HUMAN | Cytochrome c oxidase subunit 4 isoform 2, mitochondrial | PfamPF02936 |
| 6 | Cox5a | COX5A_HUMAN | Cytochrome c oxidase subunit 5A, mitochondrial | PfamPF02284 |
| 7 | Cox5b | COX5B_HUMAN | Cytochrome c oxidase subunit 5B, mitochondrial | PfamPF01215 |
| 8 | Cox6a1 | CX6A1_HUMAN | Cytochrome c oxidase subunit 6A1, mitochondrial | PfamPF02046 |
| 9 | Cox6a2 | CX6A2_HUMAN | Cytochrome c oxidase subunit 6A2, mitochondrial | PfamPF02046 |
| 10 | Cox6b1 | CX6B1_HUMAN | Cytochrome c oxidase subunit 6B1 | PfamPF02297 |
| 11 | Cox6b2 | CX6B2_HUMAN | Cytochrome c oxidase subunit 6B2 | PfamPF02297 |
| 12 | Cox6c | COX6C_HUMAN | Cytochrome c oxidase subunit 6C | PfamPF02937 |
| 13 | Cox7a1 | CX7A1_HUMAN | Cytochrome c oxidase subunit 7A1, mitochondrial | PfamPF02238 |
| 14 | Cox7a2 | CX7A2_HUMAN | Cytochrome c oxidase subunit 7A2, mitochondrial | PfamPF02238 |
| 15 | Cox7a3 | COX7S_HUMAN | Putative cytochrome c oxidase subunit 7A3, mitochondrial | PfamPF02238 |
| 16 | Cox7b | COX7B_HUMAN | Cytochrome c oxidase subunit 7B, mitochondrial | PfamPF05392 |
| 17 | Cox7c | COX7C_HUMAN | Cytochrome c oxidase subunit 7C, mitochondrial | PfamPF02935 |
| 18 | Cox7r | COX7R_HUMAN | Cytochrome c oxidase subunit 7A-related protein, mitochondrial | PfamPF02238 |
| 19 | Cox8a | COX8A_HUMAN | Cytochrome c oxidase subunit 8A, mitochondrial P | PfamPF02285 |
| 20 | Cox8c | COX8C_HUMAN | Cytochrome c oxidase subunit 8C, mitochondrial | PfamPF02285 |
| Assembly subunits[7][8][9] | ||||
| 1 | Coa1 | COA1_HUMAN | Cytochrome c oxidase assembly factor 1 homolog | PfamPF08695 |
| 2 | Coa3 | COA3_HUMAN | Cytochrome c oxidase assembly factor 3 homolog, mitochondrial | PfamPF09813 |
| 3 | Coa4 | COA4_HUMAN | Cytochrome c oxidase assembly factor 4 homolog, mitochondrial | PfamPF06747 |
| 4 | Coa5 | COA5_HUMAN | Cytochrome c oxidase assembly factor 5 | PfamPF10203 |
| 5 | Coa6 | COA6_HUMAN | Cytochrome c oxidase assembly factor 6 homolog | PfamPF02297 |
| 6 | Coa7 | COA7_HUMAN | Cytochrome c oxidase assembly factor 7, | PfamPF08238 |
| 7 | Cox11 | COX11_HUMAN | Cytochrome c oxidase assembly protein COX11 mitochondrial | PfamPF04442 |
| 8 | Cox14 | COX14_HUMAN | Cytochrome c oxidase assembly protein | PfamPF14880 |
| 9 | Cox15 | COX15_HUMAN | Cytochrome c oxidase assembly protein COX15 homolog | PfamPF02628 |
| 10 | Cox16 | COX16_HUMAN | Cytochrome c oxidase assembly protein COX16 homolog mitochondrial | PfamPF14138 |
| 11 | Cox17 | COX17_HUMAN | Cytochrome c oxidase copper chaperone | PfamPF05051 |
| 12 | Cox18[10] | COX18_HUMAN | Mitochondrial inner membrane protein (Cytochrome c oxidase assembly protein 18) | PfamPF02096 |
| 13 | Cox19 | COX19_HUMAN | Cytochrome c oxidase assembly protein | PfamPF06747 |
| 14 | Cox20 | COX20_HUMAN | Cytochrome c oxidase protein 20 homolog | PfamPF12597 |
COX assembly inyeast are a complex process that is not entirely understood due to the rapid and irreversible aggregation of hydrophobic subunits that form the holoenzyme complex, as well as aggregation of mutant subunits with exposed hydrophobic patches.[11] COX subunits are encoded in both the nuclear and mitochondrial genomes. The three subunits that form the COX catalytic core are encoded in the mitochondrial genome. Over 30 different nuclear-encoded chaperone proteins are required for COX assembly.[12]
Cofactors, including hemes, are inserted into subunits I & II. The two heme molecules reside in subunit I, helping with transport to subunit II where two copper molecules aid with the continued transfer of electrons.[13] Subunits I and IV initiate assembly. Different subunits may associate to form sub-complex intermediates that later bind to other subunits to form the COX complex.[11] In post-assembly modifications, COX will form a homodimer. This is required for activity. Dimers are connected by acardiolipin molecule,[11][14][15] which has been found to play a key role in stabilization of the holoenzyme complex. The dissociation of subunits VIIa and III in conjunction with the removal of cardiolipin results in total loss of enzyme activity.[15] Subunits encoded in the nuclear genome are known to play a role in enzyme dimerization and stability. Mutations to these subunits eliminate COX function.[11]
Assembly is known to occur in at least three distinct rate-determining steps. The products of these steps have been found, though specific subunit compositions have not been determined.[11]
Synthesis and assembly of COX subunits I, II, and III are facilitated by translational activators, which interact with the 5’ untranslated regions of mitochondrial mRNA transcripts. Translational activators are encoded in the nucleus. They can operate through either direct or indirect interaction with other components of translation machinery, but exact molecular mechanisms are unclear due to difficulties associated with synthesizing translation machinery in-vitro.[16][17] Though the interactions between subunits I, II, and III encoded within the mitochondrial genome make a lesser contribution to enzyme stability than interactions between bigenomic subunits, these subunits are more conserved, indicating potential unexplored roles for enzyme activity.[18]
 | This sectionis missing information about names of the six traditional intermediate states (APFOER); 2021 Cyro-EM result proposing an RPFOE mechanism with reversed assignment of red-ox phases (doi:10.1038/s41467-021-27174-y  ). Please expand the section to include this information. Further details may exist on thetalk page.(December 2021) |
The overall reaction is
Two electrons are passed from two cytochrome c's, through the CuA and cytochrome a sites to the cytochrome a3–CuB binuclear center, reducing the metals to the Fe2+ form and Cu+. The hydroxide ligand is protonated and lost as water, creating a void between the metals that is filled by O2. The oxygen is rapidly reduced, with two electrons coming from the Fe2+-cytochrome a3, which is converted to the ferryl oxo form (Fe4+=O). The oxygen atom close to CuB picks up one electron from Cu+, and a second electron and a proton from thehydroxyl of Tyr(244), which becomes a tyrosyl radical. The second oxygen is converted to a hydroxide ion by picking up two electrons and a proton. A third electron from another cytochrome c is passed through the first two electron carriers to the cytochrome a3–CuB binuclear center, and this electron and two protons convert the tyrosyl radical back to Tyr, and the hydroxide bound to CuB2+ to a water molecule. The fourth electron from another cytochrome c flows through CuA and cytochrome a to the cytochrome a3–CuB binuclear center, reducing the Fe4+=O to Fe3+, with the oxygen atom picking up a proton simultaneously, regenerating this oxygen as a hydroxide ion coordinated in the middle of the cytochrome a3–CuB center as it was at the start of this cycle. Overall, four reduced cytochrome c's are oxidized while O2 and four protons are reduced to two water molecules.[4]: 841–5
COX exists in three conformational states: fully oxidized (pulsed), partially reduced, and fully reduced. Each inhibitor has a high affinity to a different state. In the pulsed state, both the heme a3 and the CuB nuclear centers are oxidized; this is the conformation of the enzyme that has the highest activity. A two-electron reduction initiates a conformational change that allows oxygen to bind at the active site to the partially-reduced enzyme. Four electrons bind to COX to fully reduce the enzyme. Its fully reduced state, which consists of a reduced Fe2+ at the cytochrome a3 heme group and a reduced CuB+ binuclear center, is considered the inactive or resting state of the enzyme.[19]
Cyanide,azide, andcarbon monoxide[20] all bind to cytochrome c oxidase, inhibiting the protein from functioning and leading to the chemicalasphyxiation of cells. Higher concentrations of molecular oxygen are needed to compensate for increasing inhibitor concentrations, leading to an overall decrease in metabolic activity in the cell in the presence of an inhibitor. Other ligands, such as nitric oxide and hydrogen sulfide, can also inhibit COX by binding to regulatory sites on the enzyme, reducing the rate of cellular respiration.[21]
Cyanide is a non-competitive inhibitor for COX,[22][23] binding with high affinity to the partially-reduced state of the enzyme and hindering further reduction of the enzyme. In the pulsed state, cyanide binds slowly, but with high affinity. The ligand is posited to electrostatically stabilize both metals at once by positioning itself between them. A high nitric oxide concentration, such as one added exogenously to the enzyme, reverses cyanide inhibition of COX.[24]
Nitric oxide can reversibly[25] bind to either metal ion in the binuclear center to be oxidized to nitrite. NO and CN− will compete with oxygen to bind at the site, reducing the rate of cellular respiration. Endogenous NO, however, which is produced at lower levels, augments CN− inhibition. Higher levels of NO, which correlate with the existence of more enzyme in the reduced state, lead to a greater inhibition of cyanide.[19] At these basal concentrations, NO inhibition of Complex IV is known to have beneficial effects, such as increasing oxygen levels in blood vessel tissues. The inability of the enzyme to reduce oxygen to water results in a buildup of oxygen, which can diffuse deeper into surrounding tissues.[25] NO inhibition of Complex IV has a larger effect at lower oxygen concentrations, increasing its utility as a vasodilator in tissues of need.[25]
Hydrogen sulfide will bind COX in a noncompetitive fashion at a regulatory site on the enzyme, similar to carbon monoxide. Sulfide has the highest affinity to either the pulsed or partially reduced states of the enzyme, and is capable of partially reducing the enzyme at the heme a3 center. It is unclear whether endogenous H2S levels are sufficient to inhibit the enzyme. There is no interaction between hydrogen sulfide and the fully reduced conformation of COX.[21]
Methanol inmethylated spirits is converted intoformic acid, which also inhibits the same oxidase system. High levels of ATP canallosterically inhibit cytochrome c oxidase, binding from within the mitochondrial matrix.[26]
Cytochrome c oxidase has 3 subunits which are encoded bymitochondrial DNA (cytochrome c oxidasesubunit I,subunit II, andsubunit III). Of these 3 subunits encoded by mitochondrial DNA, two have been identified in extramitochondrial locations. Inpancreatic acinar tissue, these subunits were found inzymogen granules. Additionally, in theanterior pituitary, relatively high amounts of these subunits were found ingrowth hormone secretory granules.[27] The extramitochondrial function of these cytochrome c oxidase subunits has not yet been characterized. Besides cytochrome c oxidase subunits, extramitochondrial localization has also been observed for large numbers of other mitochondrial proteins.[28][29] This raises the possibility about existence of yet unidentified specific mechanisms for protein translocation from mitochondria to other cellular destinations.[27][29][30]
Defects involving genetic mutations altering cytochromec oxidase (COX) functionality or structure can result in severe, often fatalmetabolic disorders. Such disorders usually manifest in early childhood and affect predominantly tissues with high energy demands (brain, heart, muscle). Among the many classifiedmitochondrial diseases, those involving dysfunctional COX assembly are thought to be the most severe.[31]
The vast majority of COX disorders are linked to mutations in nuclear-encoded proteins referred to as assembly factors, or assembly proteins. These assembly factors contribute to COX structure and functionality, and are involved in several essential processes, including transcription and translation of mitochondrion-encoded subunits, processing of preproteins and membrane insertion, and cofactor biosynthesis and incorporation.[32]
Currently, mutations have been identified in seven COX assembly factors:SURF1,SCO1,SCO2,COX10,COX15,COX20,COA5 andLRPPRC. Mutations in these proteins can result in altered functionality of sub-complex assembly, copper transport, or translational regulation. Each gene mutation is associated with the etiology of a specific disease, with some having implications in multiple disorders. Disorders involving dysfunctional COX assembly via gene mutations includeLeigh syndrome,cardiomyopathy,leukodystrophy,anemia, andsensorineural deafness.
The increased reliance of neurons on oxidative phosphorylation for energy[33] facilitates the use of COX histochemistry in mapping regional brain metabolism in animals, since it establishes a direct and positive correlation between enzyme activity and neuronal activity.[34] This can be seen in the correlation between COX enzyme amount and activity, which indicates the regulation of COX at the level of gene expression. COX distribution is inconsistent across different regions of the animal brain, but its pattern of its distribution is consistent across animals. This pattern has been observed in the monkey, mouse, and calf brain. One isozyme of COX has been consistently detected in histochemical analysis of the brain.[35] Such brain mapping has been accomplished in spontaneous mutant mice with cerebellar disease such asreeler[36] and a transgenic model ofAlzheimer's disease.[37] This technique has also been used to map learning activity in the animal brain.[38]
.svg)
